知搜-全球专利检索

  1. 登录
  2. 注册

搜索结果

223 条记录 (耗时 0.038 秒)

    Determining non-nucleic acid molecule binding to target by competition with nucleic acid ligands
    3.
    发明申请
    Determining non-nucleic acid molecule binding to target by competition with nucleic acid ligands 有权
    通过与核酸配体竞争来测定与核酸分子结合的非核酸分子

    公开(公告)号：US20050048521A1

    公开(公告)日：2005-03-03

    申请号：US10746565

    申请日：2003-12-24

    申请人： Nebojsa Janjic ,  Larry Gold

    发明人： Nebojsa Janjic ,  Larry Gold

    IPC分类号： G01N33/50 ,  C12Q1/68 ,  G01N33/15 ,  G01N33/53 ,  G01N33/566 ,  G01N37/00 ,  G01N33/543

    CPC分类号： G01N33/53 ,  C12Q1/6811 ,  Y10S530/812 ,  C12Q2545/107 ,  C12Q2565/518

    摘要： A competitive binding assay is used to determine whether a non-nucleic acid molecule from a library of non-nucleic acid molecules binds to a target. The non-nucleic acid molecule competes with a labeled nucleic acid ligand for binding to the target which may be immobilized. Detecting displacement of labeled nucleic acid ligand from a complex of the labeled nucleic acid ligand and the target determines binding of the non-nucleic acid molecule to the target. The nucleic acid ligand may be immobilized and contacted with a labeled target to form a complex. Adding a non-nucleic acid molecule to the complex displaces labeled target from the complex, and detecting displacement of the labeled target determines binding of the non-nucleic acid molecule to the target. Labeled nucleic acid ligand or labeled target displaced from or remaining in the complex can be detected for detecting displacement. Nucleic acid ligands that bind to the target are identified by the SELEX method. The assay provides a high throughput screening method for determining whether a non-nucleic acid molecule binds to a target.

    摘要翻译： 使用竞争性结合测定来确定非核酸分子的文库中的非核酸分子是否与靶标结合。 非核酸分子与标记的核酸配体竞争结合靶，其可以被固定化。 检测标记的核酸配体从标记的核酸配体和靶的复合物的置换确定非核酸分子与靶标的结合。 核酸配体可以被固定化并与标记的靶接触以形成复合物。 向复合物中加入非核酸分子从复合物置换标记的靶，并且检测标记的靶的置换确定非核酸分子与靶的结合。 可以检测标记的核酸配体或从复合物中残留的残留的标记的靶标，以检测位移。 通过SELEX法鉴定与靶标结合的核酸配体。 该测定提供了用于确定非核酸分子是否结合靶的高通量筛选方法。

    Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
    5.
    发明授权
    Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes 有权
    血管内皮生长因子（VEGF）核酸配体复合物

    公开(公告)号：US06426335B1

    公开(公告)日：2002-07-30

    申请号：US09254968

    申请日：2000-03-13

    申请人： Nebojsa Janjic ,  Larry Gold ,  Paul Schmidt ,  Chandra Vargeese ,  Michael Willis

    发明人： Nebojsa Janjic ,  Larry Gold ,  Paul Schmidt ,  Chandra Vargeese ,  Michael Willis

    IPC分类号： A61K3170

    CPC分类号： A61K31/70 ,  A61K38/00 ,  A61K47/544 ,  A61K47/60 ,  C07H21/00 ,  C07K14/52 ,  C12N15/115 ,  C12N15/88 ,  C12N2310/3515

    摘要： This invention discloses a method for preparing a complex comprised of a VEGF Nucleic Acid Ligand and a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound by identifying a VEGF Nucleic Acid Ligand by SELEX methodology and associating the VEGF Nucleic Acid Ligand with a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound. The invention further discloses Complexes comprising one or more VEGF Nucleic Acid Ligands in association with a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound. The invention further includes a Lipid construct comprising a VEGF Nucleic Acid Ligand or Complex and methods for making the same.

    摘要翻译： 本发明公开了一种通过SELEX方法鉴定VEGF核酸配体并将VEGF核酸配体与非 - 免疫原性，高分子量化合物或非亲和性化合物组合的复合物， 免疫原性，高分子量化合物或亲脂性化合物。 本发明进一步公开了包含与非免疫原性，高分子量化合物或亲脂性化合物结合的一种或多种VEGF核酸配体的复合物。 本发明还包括含有VEGF核酸配体或复合物的脂质构建体及其制备方法。

    Lung Cancer Biomarkers and Uses Thereof
    8.
    发明申请
    Lung Cancer Biomarkers and Uses Thereof 审中-公开
    肺癌生物标志物及其用途

    公开(公告)号：US20130116150A1

    公开(公告)日：2013-05-09

    申请号：US13808751

    申请日：2011-07-11

    申请人： Sheri Wilcox ,  Deborah Ayers ,  Nebojsa Janjic ,  Larry Gold ,  Michael Riel-Mehan ,  Thale Jarvis

    发明人： Sheri Wilcox ,  Deborah Ayers ,  Nebojsa Janjic ,  Larry Gold ,  Michael Riel-Mehan ,  Thale Jarvis

    IPC分类号： G01N33/68 ,  G06F19/10 ,  C12Q1/68

    CPC分类号： G01N33/6893 ,  C12Q1/6886 ,  C12Q2600/106 ,  C12Q2600/112 ,  C12Q2600/156 ,  C12Q2600/16 ,  G01N33/57423 ,  G16B20/00 ,  G16B25/00 ,  G16B40/00 ,  G16B99/00

    摘要： The present application includes biomarkers, methods, devices, reagents, systems, and kits for the detection and diagnosis of lung cancer. In one aspect, the application provides biomarkers that can be used alone or in various combinations to diagnose lung cancer or permit the differential diagnosis of pulmonary nodules as benign or malignant. In another aspect, methods are provided for diagnosing lung cancer in an individual, where the methods include detecting, in a biological sample from an individual, at least one biomarker value corresponding to at least one biomarker selected from the group of biomarkers provided in Table 18, Table 20, or Table 21, wherein the individual is classified as having lung cancer, or the likelihood of the individual having lung cancer is determined, based on the at least one biomarker value.

    摘要翻译： 本申请包括用于肺癌的检测和诊断的生物标志物，方法，装置，试剂，系统和试剂盒。 在一个方面，该应用提供可以单独使用或以各种组合使用以诊断肺癌或允许肺结节的鉴别诊断为良性或恶性的生物标志物。 在另一方面，提供了用于诊断个体中的肺癌的方法，其中所述方法包括在来自个体的生物样品中检测至少一种对应于选自表18中提供的生物标志物组的至少一种生物标志物的生物标记值 ，表20或表21，其中基于所述至少一种生物标记值将个体分类为具有肺癌或确定患有肺癌的个体的可能性。